Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Neuroprotective Effect of High Dose Erythropoietin in Very Preterm Infants
Brief Summary:
The main goal of this trial is to investigate whether early administration of human erythropoietin (EPO) in very preterm infants improves neurodevelopmental outcome at 24 months corrected age.
This study is designed as randomized, double-masked, placebo controlled multicenter study involving at least 420 patients.